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Background. We have shown that approximately 30% of human peripheral blood B-cells express CD25. B cells expressing CD25
display a mature phenotype belonging to the memory B-cell population and have a better proliferative and antigen-presenting
capacity. The aim of the present study was to characterize the CD25-expressing subset of B cells in human cord blood. Material
and Methods. Mononuclear cell fraction from human cord blood (n = 34) and peripheral adult blood (n = 22) was sorted into
CD20+CD25+ and CD20+CD25− B-cell populations. Phenotype and function of these B-cell populations were compared using
ﬂow cytometry, proliferation, cytokine production, and immunoglobulin secretion. Results. CD25-expressing B cells are a limited
population of cord blood mononuclear cells representing 5% of the CD20+ B cells. They are characterised by high expression of
CD5 in cord blood and CD27 in adult blood. CD25-expressing B cells express a functional IL-2 receptor and high levels of CC-
chemokine receptors and spontaneously produce antibodies of IgG and IgM subclass. Conclusions. CD25 expression is a common
denominator of a speciﬁc immunomodulatory B-cell subset ready to proliferate upon IL-2 stimulation, possibly ready to migrate
and home into the peripheral tissue for further diﬀerentiation/action.
1.Introduction
B cells are important players of the immune system due to
immunoglobulin production and ability to present antigens
and to secrete various cytokines. Using diﬀerent surface
marker expression, the B-cell population can be divided
into distinct subsets that are of importance during diﬀerent
immunological events (i.e., immature B cells, na¨ ıve B cells,
memory B cells, plasma cells, B1 and B2, germinal centre, or
marginal zone B cells).
In cord blood, the B-cell population is somewhat en-
riched as compared to adult peripheral blood. The mean fre-
quency of B cells is about 11% as compared to approximately
5% in adult peripheral blood [1]. However, information
regarding function and phenotype of B-cell subsets in cord
blood is scanty. Recent studies by Griﬃn et al. [2]a n d
Ichii et al. [3] have shown that human cord blood B
cells may be divided into diﬀerent subpopulations both
phenotypically and functionally but more need to be done
to fully understand early development of the B cells and their
contribution in health and disease.
It has been shown that CD5 is expressed on the ﬁrst B
cells detectable in the fetal liver and developing lymph nodes
suggesting that CD5 may also be a marker of origin [4]. In
cord blood, it has been shown that almost 60–80% of the
B cells express CD5, and the expression decreases with age,
ﬁnally ending up with a frequency of 5–30% in adult B cells
[5, 6]. Furthermore, CD5 can be used for dividing mouse B
cells into B1 and B2 B cells where B1a B cells express CD5
and B2 represent the conventional B cells [7–11]. The B1 B
cells have been shown to produce low-aﬃnity polyreactive
immunoglobulins, both in mice and humans, recognising
several autoantigens as well as many bacterial antigens (i.e.,
lipopolysaccharides and polysaccharides) [12–15]. Interest-
ingly, CD5-expressing B cells have been suggested to follow
separate distinct developmental pathways [16–18]. However,2 Clinical and Developmental Immunology
recent multiple studies have shown the expression of CD5 on
other subsets of B cells than B1 B cells in humans indicating
that a combination of markers including the CD5 is needed
to correctly identify these cells in both humans and mice
[19].
In adults, the B-cell production has switched from liver
to be exclusively generated and matured in the bone marrow.
The type 1 glycoprotein, CD27, is expressed on memory B
cells and plasmablasts and can be found on approximately
40% of all circulating B cells in adults [20, 21]. In contrast,
Agematsu et al. have shown that in cord blood the CD27-
expressing population is found to be approximately 3% with
increasing numbers with aging.
We have previously described a subpopulation of im-
munoregulatory B cells based on the expression of the
surface marker CD25 [22]. The CD25+ B cells isolated
from peripheral blood have diﬀerent phenotypical and
functional properties as compared to CD25− B cells [22].
The expression of CD25 is rapidly increased following
toll-like-receptor-mediated cell stimulation, resulting in the
expression of a fully functional IL-2R. This mechanism
of IL-2R activation is nuclear factor-kappa β dependent.
CD25+ B cells display a more mature and activated phe-
notype and belong to a subclass of memory B cells, based
on analysis of immunoglobulins (Ig) expression, surface
expression of the memory marker CD27, and the costimu-
latory molecule CD80 [22, 23]. Functionally, they seem to
work as immunomodulatory B cells by better function as
antigen-presenting cells and secreting the immunosuppres-
sive cytokine IL-10, as compared to CD25− B cells [22, 23].
In contrast, very few CD25+ B cells secrete immunoglobulins
when compared to CD25− B cells. Moreover, the prolif-
erative response to IL-2 may suggest that CD25+ Bc e l l s
express a fully functional high-aﬃn i t yI L - 2r e c e p t o r( I L - 2 R )
[22, 23].
By use of freshly collected cord blood, we studied
phenotype and function of CD25+ B cells as compared to
CD25+ B cells isolated from adult peripheral blood, or to
CD25− B cells from cord blood. We found that only a few
percentages of the cord blood B cells (CBC) expressed CD25.
However, they expressed the complete high-aﬃnity IL-2R,
and the receptor was fully functional. A coexpression of
higher frequency of CD5 on these cells may suggest a subset
of B1 B cells in cord blood, but further more in depth studies
are needed to evaluate this hypothesis. It seems like the
CD25+ CBC already are designated to develop to memory
B cells and are highly mobile due to a high expression
of homing receptors. Finally, they spontaneously secrete
immunoglobulins of the IgG and IgM subclass.
2.MaterialandMethods
2.1. Healthy Individuals. 34 mothers giving birth at M¨ olndal
Hospital in G¨ oteborg, Sweden gave their informed consent
to donate cord blood after delivery. From the cord, 10–
50mL blood was drawn into tubes containing heparin.
Heparinized peripheral blood samples from 22 adult blood
donors(age30–65years)wasusedascontrols.Thisstudywas
approvedbytheethicalcommitteeatUniversityofG¨ oteborg,
G¨ oteborg, Sweden.
2.2. Cell Preparation. Peripheral blood mononuclear cells
were isolated by density gradient centrifugation using lym-
phoprep (Axis-Shield, Oslo, Norway). For B-cell preparation
cells were washed twice in phosphate buﬀered saline (PBS),
the unspeciﬁc binding of antibodies by Fc-receptors was
blockedwith5%fetalcalfserum(FCS)for5minutesinroom
temperature (RT) followed by staining of cells surface CD20
(2H7 or L27, BD-Bioscience, Erembodegem, Belgium) and
CD25 (2A3, BD-Bioscience) for 30 minutes in 4◦ and sorted
using FACSAria (BD-Bioscience).
2.3. Phenotypic Analysis of B Cells. Phenotypic analysis of
the cells was performed with a ﬂuorescence-activated cell
sorter (FACS) as described [22, 23]. The following mouse
antihuman monoclonal antibodies (mAbs) were used: anti-
CD5 (clone UCHT2), anti-CD20 (2H7 or L27), anti-CD25
(2A3), anti-CD27 (LI28), anti-CD80 (L307.4), anti-CD86
(2331), anti-CD122 (Mik-β3), anti-CD132 (Tugh4), and L-
selectin (SK11), all purchased from BD, also CCR9 (112509),
CCR7 (150503), CCR4 (205410), and CCR10 (314305), all
purchased from R&D systems, Abingdon, UK. As isotype
controls, mouse monoclonal IgG1 antibodies (clone X40 or
PK136) directed against keyhole limpet hemocyanin were
used.
Surface immunoglobulin (IgA, IgD, IgG, and IgM)
staining was performed using FITC-conjugated F(ab )2 frag-
ments of goat antihuman γ-, μ-, and α-speciﬁc antibodies
(DakoCytomation,Glostrup,Denmark).Asisotypecontrols,
we used an irrelevant goat antihuman FITC-conjugated
F(ab )2 fragment also purchased from (DakoCytomation).
2.4. Proliferation. Sorted CD20+CD25+ or CD20+CD25− B
c e l l sw e r es t i m u l a t e dw i t hr h - I L - 2( 2 5 U )( R & Ds y s t e m s )
and cultured at 2.5 × 105 cells per well in RPMI medium
containing 10% FCS, 1% gentamicin, 1% L-glutamine, and
1% mercaptoethanol, complete culture medium (all from
Sigma-Aldrich) in round-bottomed ninety-six well plates
at a ﬁnal volume of 200μL. Cultured cells were incubated
in a humidiﬁed atmosphere containing 5% CO2 at 37◦
and pulsed with [3H]-thymidine (Amersham Pharmacia
Biotech, Little Chalfont, UK) for last 8h of 96h culture. The
cells were harvested onto glass ﬁlters and dried, whereafter
incorporated [3H]-thymidine was measured using a β-
scintillation counter.
2.5. Cell Stimulation. 2.5 × 104 of CD20+CD25+ or
CD20+CD25− B cells per well were cultured in complete cul-
ture medium in round-bottomed ninety-six well plates at a
ﬁnal volume of 100μL .C e l l sw e r ec u l t u r e di nm e d i u ma l o n e
or stimulated either with 3μM backbone protected CpG-
S5  -TCGTCGTTTTGTCGTTTTGTCGTT-3  (Scandinavian
Gene Synthesis AB, K¨ oping, Sweden), 5μg/mL Pam3Cys
(EMC Microcollections, T¨ ubingen, Germany), or 25U rIL-2
(R&D systems) in a humidiﬁed atmosphere containingClinical and Developmental Immunology 3
5% CO2 at 37◦. Supernatants collected following 48h and
72h of stimulations were stored at −70◦ until used.
2.6. Cytometric Bead Array (CBA). Cytokine (IL-2, IL-4, IL-
6, IL-10, and IFN-γ) levels in supernatants were measured
using the human Th1/Th2 cytokine CBA kit according to
the manufacturers protocol (BD-Bioscience) and analysed
using the FCAP array software (Soft Flow Inc, Minn,
USA).
2.7. ELISPOT. Spontaneous secretion of antibodies from
2 × 104 CD20+CD25+ and CD20+CD25− B cell subsets
was detected by the enzyme-linked immunosorbent spot
(ELISPOT) technique as described in [22].
2.8. Statistical Evaluation. To calculate statistical diﬀerences,
we used the parametric unpaired t-test when comparing
results from cord blood versus results from adult blood,
whereas when comparing results within each group, the
paired t-test was used. ∗P ≤ 0.01, ∗∗P ≤ 0.001, and ∗∗∗P ≤
0.0001.
3. Results
3.1. IL-2R Expression on B Cells Isolated from Cord Blood
as Compared to Adult Peripheral B Cells. When analysing
the surface expression of the IL-2R alpha subunit CD25
on B cells isolated from human umbilical cord blood, we
found a signiﬁcantly lower frequency (approximately 5%)
as compared to B cells isolated from adult peripheral blood
(approximately 25%) (P ≥ 0.0001) (Figure 1(a)). Interest-
ingly, when dividing the CBC into CD25+ and CD25− cells,
analysing the expression of the other two subunits of the IL-
2R (CD122 and CD132) CD25+ CBC expressed signiﬁcantly
higher frequencies as compared to adult corresponding cells
(P ≥ 0.002 and P ≥ 0.0001, resp.) (Figures 1(a) and 1(f)).
Comparing CD25+ and CD25− CBC regarding the
expression of CD122 and CD132, the CD25+ population
displayed signiﬁcantly higher frequencies (P ≥ 0.006, P ≥
0.0001) (Figures 1(b) and 1(f)). In contrast, the adult CD25-
expressing B-cells only displayed a higher frequency of
CD122 as compared to the CD25− B-cell population (P ≥
0.02) (Figure 1(f)).
When analysing the median ﬂuorescence intensity of the
CD122 and CD132 expression on CD25+ and CD25− from
CBC and adult blood, we found an increased intensity of
CD122 but a decreased intensity of CD132 on CD25+ B
cells from CBC (P ≥ 0.03 and P ≥ 0.04) (Figures 1(c)
and 1(f)). On adult CD25+ B cells, the intensity of both
CD132 and CD132 was increased (P ≥ 0.01, P ≥ 0.002)
(Figures 1(c) and 1(g)).
3.2. CD25+ CBC Express a Fully Functional IL-2 Receptor.
To investigate if CD25+ CBC not only expressed the high-
aﬃnity IL-2 receptor but also if it was fully functional,
we stimulated the CBC subpopulations with rh-IL-2. We
found that CD25+ CBC proliferated signiﬁcantly more in
response to rh-IL2 as compared to CD25− CBC (P ≥ 0.04)
(Figure 1(j)). To role out that the detected increased pro-
liferation of the CD25+ CBC following rh-IL-2 stimulation
was dependent on an increased CD25 expression, we also
analysed the CD25 expression on CBC following 24h of
rh-IL-2 addition. No increased CD25 expression could be
detected on CBC following 24h of rh-IL-2 stimulation (data
not shown).
3.3. CD25+CBC Express Both CD5 and the Human B-Cell
MemoryMarkerCD27. Tofurtherdeterminethematuration
andmemorystatusonCD25+ CBC,weexaminedthesurface
expression of CD5 and CD27 on these cells. We found
that CD25+ CBC expressed a signiﬁcantly higher frequency
of CD5 as compared to the corresponding population of
ABC (P ≥ 0.0001) (Figure 2(a)). On CD25+ CBC, almost
85% expressed CD5 as compared to 55% of the CD25−
CBC (P ≥ 0.0001) (Figure 2(a)). In sharp contrast, only
10% of the adult CD25+ B cells expressed CD5, and a
signiﬁcantly increased frequency was found on the CD25−
B-cell population (P ≥ 0.0049) (Figure 2(a)).
Analysing the surface expression of the human memory
marker CD27 on CD25+ CBC, we found a signiﬁcantly
lower frequency of CD27 than the corresponding ABC (P ≥
0.0001) (Figure 2(b)).
Comparing CD25+ CBC to CD25−CBC, a signiﬁcantly
higher frequency (P ≥ 0.0019) of CD27 was detected on the
CD25+ CBC (Figure 2(b)) .T h es a m er e s u l tw a sf o u n do n
the CD25+ ABC compared to CD25− B cells (P ≥ 0.0001)
(Figure 2(b)).
3.4. CD25+ CBC Display Similar Immunoglobulin Expression
Compared to CD25+ ABC. When comparing CD25+ CBC
to CD25+ ABC regarding the surface expression of the
immunoglobulins A, D, G, and M, we found no statistical
signiﬁcant diﬀerences between the two groups, even though
adult CD25+ B cells displayed a clear trend of more IgA and
IgG expressing cells.
CD25+ CBCexpressedsigniﬁcantlyincreasedfrequencies
of IgM (P ≥ 0.0001) but a decreased frequency of IgD
(P ≥ 0.0061) as compared to CD25− CBC (Figure 3(a)). The
surface expression of IgG and IgA on CBC was very low, and
accordingly, no diﬀerences in the frequency of IgG and IgA
expression were found between the two groups.
In contrast, CD25+ ABC displayed a signiﬁcantly higher
frequency of IgG (P ≥ 0.0001) and IgA (P ≥ 0.0007), but
al o w e rI g D( P ≥ 0.0005) expression as compared to the
CD25− B cells (Figure 3(a)).
3.5. CD25+ CBC Spontaneously Secrete IgG and IgM In Vitro.
SortedCD25+ CBCwerecomparedtoCD25− CBCregarding
their ability to secrete IgM, IgG, and IgA using ELISPOT.
Interestingly, we found a signiﬁcantly increased numbers of
IgG, and IgM secreting CD25+ CBC as compared to CD25−
CBC (P ≥ 0.05 for both) (Figures 3(b) and 3(c)). No or
onlyafewcellssecretedIgA,andnodiﬀerencesweredetected
between the populations (data not shown).
3.6. CD25+ CBC Display High Frequencies of Homing Recep-
tors. To investigate the capacity of migration to diﬀerent4 Clinical and Developmental Immunology
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Figure 1: Expression and functional evaluation of the IL-2R on cord blood and adult CD20+ Bc e l l s . From freshly isolated cord blood
(N = 1 0 )o ra d u l tb l o o d ,m o n o n u c l e a rc e l l s( N = 10) were isolated by density gradient centrifugation. Cells were stained for 3-colour ﬂow
cytometry analysis using a combination of CD20, CD25, CD122, or CD132. (a) shows the CD25 expression on CD20+ cells isolated from
cord blood or adult blood. In (b), the CD122 expression and in (f) the CD132 expression are analysed on CD25+ and CD25− CD20+ Bc e l l s
isolatedfromcordbloodoradultblood.In(c)themedianintensityofCD122andin(g)themedianintensityofCD132areshownonCD25+
and CD25− CD20+ B cells isolated from cord blood or adult blood. (d) and (h) show a representative histogram of CD122 (d) and CD132
expression on CD25+ and CD25− cord blood B cells. Black line indicates CD25+ and ﬁlled histogram represent CD25− cord blood Bcells. (e)
and (i) show a representative histogram of CD122 (d) and CD132 expression on CD25+ and CD25− adult B cells. Black line indicates CD25+
andﬁlledhistogramrepresentCD25− adultBcells.Finally,in(j),theproliferationof 3H-thymidinelabelledsortedCD25+ andCD25−CD20+
B cells isolated from cord blood (N = 6) is shown following 96h of stimulation with 25U rh-IL-2. Line in boxes represents median. Statistical
evaluation was performed using the parametric unpaired t-test when comparing results from cord blood versus results from adult blood,
whereas when comparing results within each group, the paired t-test was used. ∗P ≤ 0.01, ∗∗P ≤ 0.001, and ∗∗∗P ≤ 0.0001.
tissues in the body, we examined the expression of selected
homing receptors (i.e., CCR4, CCR7, CCR9, CCR10, and L-
selectin) on CD25+ and CD25− CBC and compared them
to each other or to corresponding ABC. We found that
CD25+ CBC expressed CCR4, CCR7, and CCR9 when com-
pared to the corresponding population in adults, this was
a signiﬁcantly increased expression (Table 1). In contrast,
CD25+ CBC expressed signiﬁcantly decreased frequencies
of L-selectin as compared to CD25+ B cells from adults
(Table 1).
Furthermore, the frequency of the CCR4, CCR7, CCR9,
CCR10, and L-selectin expression was signiﬁcantly increased
on CD25+ as compared to CD25− CBC (Table 1).
Analysing CD25+ ABC, we found that frequency of
CCR4,CCR7,CCR9,CCR10,andL-selectinwassigniﬁcantly
increased as compared to CD25− B cells (Table 1).Clinical and Developmental Immunology 5
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Figure 2: Expression of the CD5 and CD27 epitopes in CD25+ and CD25− CD20+ B cells isolated from cord blood and adult blood. From
f r e s h l yi s o l a t e dc o r db l o o d( N = 10) or adult blood, mononuclear cells (N = 10) were isolated by density gradient centrifugation. Cells were
stained for 3-colour ﬂow cytometry analysis using a combination of CD20, CD25, CD5, or CD27. In (a) the CD5 and in (b) the CD27
expression on CD25+ and CD25− CD20+, B cells isolated from cord blood or adult blood are shown. Line in boxes represents median.
Statistical evaluation was performed using the parametric unpaired t-test when comparing results from cord blood versus results from adult
blood, whereas when comparing results within each group, the paired t-test was used. ∗P ≤ 0.01, ∗∗P ≤ 0.001, ∗∗∗P ≤ 0.0001.
3.7. Expression of the Costimulatory Molecules CD80 and
CD86 on CD25+ CBC as Compared to CD25+ ABC. When
comparing the costimulatory molecule expression of CD80
and CD86 on CD25+ B cells from CBC to the corresponding
ABC population, we found that the CD80 frequency was
signiﬁcantly decreased on the CD25+ CBC (Table 1). In
contrast, the frequency of CD86 was signiﬁcantly increased
on the CD25+ CBC as compared to the CD25+ ABC
(Table 1).
Furthermore, CD25+ CBC displayed a signiﬁcantly in-
creasedfrequencyofCD80andCD86ascomparedtoCD25−
B cells (Table 1). On CD25+ ABC, only CD80 expression
was signiﬁcantly increased as compared to CD25− Bc e l l s
(Table 1).
3.8. Cytokine Production from CD25+ B Cells from CBC.
Following addition with selected stimulus for 48 or 72
hours,analysisofcytokinesecretionfromCD25+ andCD25−
CBC into the supernatants was performed. No signiﬁcant
diﬀerences could be detected for any of the investigated
cytokines (i.e., IL-2, IL-4, IL-6, IL-10, or INF-γ) (data not
shown).
4. Discussion
In the present study, we have investigated CD25-expressing B
cells from the human cord blood. We have been able to show
that cord blood B cells express signiﬁcantly lower frequency
of CD25 when compared to adult B cells that express CD25
in about 30%. Further, we have found that the CD25+ Bc e l l s
fromcordbloodexpressedafullyfunctionalhigh-aﬃnityIL-
2 receptor, proven by the signiﬁcantly increased proliferation
seen following stimulation with rh-IL-2 in vitro.W eh a v e
previously shown that adult CD25+ B cells proliferate in
response to IL-2 [22]. Using our new results, we can see
that CD25+ CBC have the capacity to proliferate in the same
extent as adult peripheral cells. This suggests that CD25+
CBC have the ability to respond and multiply in situations
where IL-2 levels are increased.
Furthermore, cord blood CD25+ B cells also expressed
increased frequencies of CD122 and CD132. We found
increased intensity of CD122 but decreased intensity of
CD132 on cord blood CD25+ B cells. Since CD122 is part of
the IL-15R, and the common gamma chain, CD132, is part
of IL-4R, IL-7R, and IL-9R, these cells may respond to other
cytokines too. Many of these cytokines are involved in early
maturation processes of B cells [24].
We continued our investigation by analysing the CD5
expression on these cells. It has been postulated that CD5
is expressed on less mature B cells and is known to be
downregulated when the B cells mature with age [5, 6,
25]. In mice, CD5 expression is associated with the B1a
Bc e l ls u b c l a s s[ 7–11] .As u b c l a s st h a ts e c r e t e sl o w - a ﬃnity
IgM antibodies usually is directed against bacterial cell
wall components [12–15]. However, in humans, this B1a
population has not been clearly veriﬁed, published data
suggests that similar subclasses of B cells may exist, and, in
fact, it has been suggested that CD5-expressing B-cell subsets
are involved in the production of autoreactive antibodies
[12–15] and reviewed in [26]. Recent publication describing
a human B1 subset of B cells has however shown that these
cells may be CD5 negative but express CD27 and CD43 [2],
We found a clear distinction between cord blood CD25+
and adult blood CD25+ B cells regarding the expression
of the CD5 and memory CD27 epitopes. Even though the
discussion regarding B1 B cells in humans is still ongoing,
we may speculate that CD25-expressing B cells may be part6 Clinical and Developmental Immunology
0
50
100
150
200
I
m
m
u
n
o
g
l
o
b
u
l
i
n
e
x
p
r
e
s
s
i
o
n
(
%
)
Cord blood
IgD
IgM
IgG
IgA
∗∗∗
Adult blood
∗∗
CD25+ CD25−
∗∗∗
∗∗ ∗∗
CD25+ CD25−
(a)
0
50
100
150
Cord blood
∗
I
g
G
s
e
c
r
e
t
i
n
g
c
e
l
l
s
/
1
0
0
.
0
0
0
B
c
e
l
l
s
CD25+ CD25−
(b)
0
50
100
150
I
g
M
s
e
c
r
e
t
i
n
g
c
e
l
l
s
/
1
0
0
.
0
0
0
B
c
e
l
l
s ∗∗
Cord blood
CD25+ CD25−
(c)
Figure 3: Analysis of surface immunoglobulin expression and secretion from CD25+ and CD25− CD20+ B cells isolated from cord blood
and adult blood. In (a) freshly isolated cord blood (N = 10) or adult blood, mononuclear cells (N = 10) were isolated by density gradient
centrifugation. Cells were stained for 3-colour ﬂow cytometry analysis using a combination of CD20, CD25, IgG, IgA, IgM, and IgD. In (a), a
summaryofall4surfaceimmunoglobulinsexpressedbytheCD20+CD25+ orCD20+CD25− Bcellsisshown.RedcolourrepresentsIgD,blue
colourrepresentsIgM,yellowcolourrepresentsIgG,andgreencolourrepresentsIgA.In(b)and(c),freshlyisolatedcordbloodmononuclear
cells (N = 6) were isolated by density gradient centrifugation followed by ﬂow cytometry sorting into CD20+CD25+ or CD20+CD25−
populations. These populations were then analysed for the capacity to secret either IgG (b) or IgM (c) by use of ELISPOT. Line in boxes
represents median. Statistical evaluation was performed using the parametric unpaired t-test when comparing results from cord blood
versus results from adult blood, whereas when comparing results within each group, the paired t-test was used. ∗P ≤ 0.01, ∗∗P ≤ 0.001, and
∗∗∗P ≤ 0.0001.
of a subset belonging to B1 cells, at least in cord blood and
during the early life.
Antibody production is one of the main functions of
the B cells. We were able to show that cord blood CD25+
B cells have the ability to spontaneously secrete antibodies.
This secretion was not as eﬃc i e n ta st h ea d u l tc o u n t e r p a r ta s
we previously have shown [22]. Though, we did not analyze
the speciﬁcity of these antibodies, we believe our results are
of interest as they show that CD20+CD25+ Bc e l l si nc o r d
blood coexpressing CD5 and CD27 are not just activated B
cells but have the ability to produce antibodies of IgM and
IgG isotype. These results need further investigation to fully
understand the origin and function of these cells.
B cells have been shown to produce a line of various
cytokines [27, 28], In the last decade, the upcoming subset
of regulatory B cells with the capacity to produce IL-10
and downregulate inﬂammation in a line of animal disease
models has further indicated the importance of cytokine
productionbyBcells[29,30].Inourpreviousstudy,weshow
that CD25 + B cells from peripheral adult blood do produce
IL-10 after TLR stimulation [23]. Here, we did not see any
diﬀerence when comparing two subsets of the B cells inClinical and Developmental Immunology 7
Table 1: Comparison of homing receptor and activation marker expression between CD20+CD25+ or CD20+CD25− cells isolated from
human cord blood or from adult peripheral blood.
Cord blood Adult peripheral blood P value
CD20+CD25+ CD20+CD25− CD20+CD25+ CD20+CD25−
CCR4 35.7 ±5.53 .0 ±0.93 10.8 ±0.77 6.4 ±0.85
0.0006†
0.0001‡
0.001§
CCR7 94.1 ±1.46 8 .3 ±3.18 4 .5 ±2.77 6 .1 ±3.7
0.0001
0.003
0.006
CCR9 20.0 ±3.53 .9 ±0.91 0 .6 ±1.48 .2 ±1.5
0.002
0.005
0.03
CCR10 17.5 ±4.63 .1 ±2.61 6 .5 ±1.51 2 .9 ±1.4
0.003
0.001
n.s
L-selectin 87.4 ±3.57 3 .6 ±6.99 7 .8 ±0.79 4 .8 ±0.8
0.006
0.003
0.04
CD80 3.8 ±3.30 .68 ±0.08 21.9 ±2.58 .8 ±1.9
0.04
0.0006
0.03
CD86 10.3 ±3.82 .5 ±0.37 0.63 ±0.32 0.63 ±0.23
0.02
n.s
0.05
Values are expressed as frequency of expression in % ± SEM.
†Comparison between cord blood CD20+CD25+ and CD20+CD25−.
‡Comparison between peripheral adult blood CD20+CD25+ and CD20+CD25−.
§Comparison between cord blood CD20+CD25+ and peripheral adult blood CD20+CD25−.
cord blood regarding the cytokine production. However, we
cannot conclude that these cells do not produce cytokines in
lowlevelsafterspeciﬁcstimulationordoneedtobeactivated
in the presence of other immunological cell types in order to
produce them.
To further characterise the CD25+ CBC, we choose to
investigate the CC-chemokine receptor expression on these
cells. We found that the expression of homing receptors was
increasedinbothCD25+ Bcellsisolatedfromcordbloodand
from adult peripheral blood as compared to CD25− B cells.
Homings receptors are expressed by various immune cells in
order to migrate to the sight where they will be needed. We
found higher expression of CCR7, involved in B-cell homing
tosecondarylymphoidtissueandT-cellzone[31]andhigher
expression of CCR9 and CCR10 both homing receptors
involved in homing to intestinal tissue [32, 33] on CD25+
B cells in cord blood. This is just a phenotypical analysis but
may be an indication for the function or upcoming function
of these cells. Interestingly, when CD25+ B cells are isolated
from adult peripheral blood, the homing receptor expression
seemstobedownregulatedascomparedtoCD25+ CBC.This
might suggest that CD25+ B cells during fetal life may be of
importance for colonising the peripheral immune organs.
Conclusively, we found that cord blood CD25+ Bc e l l s
share some characteristics to adult corresponding cells
that is expression of a fully functional IL-2 receptor and
increased expression of activation and memory markers.
The similarities in homing receptor expression also suggest
a highly mobile phenotype, and the capacity of CD25+
CBC to spontaneously secrete immunoglobulins suggests a
protective role and important properties in the immune
regulation early in life.
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